Videos

Anne Chiang, MD, PhD, discusses the management of ​immune-related adverse effects in lung cancer. 

Dr. Chiang on the Management of Immune-Related AEs in Lung Cancer  

Articles

Marianne Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP, discusses the management of immune-related adverse effects in patients who are receiving treatment with checkpoint inhibitors.

Navigating Immune-Related Adverse Effects in Oncology

In a new study by Yale Cancer Center, researchers have demonstrated that in states with expanded Medicaid coverage through the Affordable Care Act a higher percentage of women with breast cancer had their disease diagnosed at an early stage.

Yale Cancer Center Study Shows Breast Cancer Detected Earlier in States with Expanded Medicaid Coverage

Markus Müschen, MD, PhD, has been named the inaugural Director of the Center of Molecular and Cellular Oncology at Yale Cancer Center and Smilow Cancer Hospital.

Müschen Named Inaugural Director of Center of Molecular and Cellular Oncology at Yale Cancer Center and Yale School of Medicine

One of the major mysteries in treating patients with COVID-19 is the frequent development of blood clots that can subsequently damage their organs and sometimes be fatal.

COVID-19 Blood Clotting Cause Identified in Study Led by Yale Cancer Center Researchers

Yale Cancer Center researchers were awarded a $2.8 million grant from the National Cancer Institute to evaluate and model cytokine signaling related to immunotherapy for cancer. 

Yale Cancer Center

Latest from Yale Cancer Center

New content coming soon, please check back later.